1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Community Acquired Pneumonia Global Clinical Trials Review, H2, 2014

Community Acquired Pneumonia Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Community Acquired Pneumonia Global Clinical Trials Review, H2, 2014" provides data on the Community Acquired Pneumonia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Community Acquired Pneumonia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Community Acquired Pneumonia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Community Acquired Pneumonia Global Clinical Trials Review, H2, 2014
Table of Contents

Introduction 6
Community Acquired Pneumonia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Community Acquired Pneumonia to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Community Acquired Pneumonia to Infectious Disease Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Community Acquired Pneumonia 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Community Acquired Pneumonia Therapeutics Clinical Trials 30
Prominent Drugs 31
Latest Clinical Trials News on Community Acquired Pneumonia 32
Oct 03, 2014: FDA Grants Durata Therapeutics a Special Protocol Agreement for Its Phase 3 Study of DALVANCE in Hospitalized Community-Acquired Pneumonia 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Pfizer Inc. 33
Clinical Trial Overview of Pfizer Inc. 33
TaiGen Biopharmaceuticals Holdings Limited 35
Clinical Trial Overview of TaiGen Biopharmaceuticals Holdings Limited 35
Sanofi 36
Clinical Trial Overview of Sanofi 36
Actavis plc 37
Clinical Trial Overview of Actavis plc 37
Bayer AG 38
Clinical Trial Overview of Bayer AG 38
Melinta Therapeutics, Inc 39
Clinical Trial Overview of Melinta Therapeutics, Inc 39
Novartis AG 40
Clinical Trial Overview of Novartis AG 40
GlaxoSmithKline plc 41
Clinical Trial Overview of GlaxoSmithKline plc 41
AstraZeneca PLC 42
Clinical Trial Overview of AstraZeneca PLC 42
Abbott Laboratories 43
Clinical Trial Overview of Abbott Laboratories 43
Clinical Trial Overview of Top Institutes / Government 44
St. Antonius Hospital 44
Clinical Trial Overview of St. Antonius Hospital 44
University Hospital Basel 45
Clinical Trial Overview of University Hospital Basel 45
University of Milan 46
Clinical Trial Overview of University of Milan 46
HaEmek Medical Center 47
Clinical Trial Overview of HaEmek Medical Center 47
Medical Center Alkmaar 48
Clinical Trial Overview of Medical Center Alkmaar 48
Spanish National Health System 49
Clinical Trial Overview of Spanish National Health System 49
Carlos III Health Institute 50
Clinical Trial Overview of Carlos III Health Institute 50
Nagasaki Evaluation Organization for Clinical Interventions 51
Clinical Trial Overview of Nagasaki Evaluation Organization for Clinical Interventions 51
Ono Municipal Hospital 52
Clinical Trial Overview of Ono Municipal Hospital 52
University of Roma La Sapienza 53
Clinical Trial Overview of University of Roma La Sapienza 53
Five Key Clinical Profiles 54
Appendix 101
Abbreviations 101
Definitions 101
Research Methodology 102
Secondary Research 102
About GlobalData 103
Contact Us 103
Disclaimer 103
Source 103

List of Tables

Community Acquired Pneumonia Therapeutics, Global, Clinical Trials by Region, 2014* 7
Community Acquired Pneumonia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Community Acquired Pneumonia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Community Acquired Pneumonia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Community Acquired Pneumonia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Community Acquired Pneumonia Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Community Acquired Pneumonia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Community Acquired Pneumonia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Community Acquired Pneumonia to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
Community Acquired Pneumonia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Community Acquired Pneumonia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Community Acquired Pneumonia to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
Community Acquired Pneumonia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Community Acquired Pneumonia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Community Acquired Pneumonia Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Community Acquired Pneumonia Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Community Acquired Pneumonia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Community Acquired Pneumonia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Community Acquired Pneumonia Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Community Acquired Pneumonia Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Community Acquired Pneumonia Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Community Acquired Pneumonia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Community Acquired Pneumonia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Community Acquired Pneumonia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Community Acquired Pneumonia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Community Acquired Pneumonia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 33
Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by TaiGen Biopharmaceuticals Holdings Limited, 2014* 35
Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 36
Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2014* 37
Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014* 38
Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Melinta Therapeutics, Inc, 2014* 39
Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 40
Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 41
Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 42
Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014* 43
Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Antonius Hospital, 2014* 44
Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Basel, 2014* 45
Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Milan, 2014* 46
Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by HaEmek Medical Center, 2014* 47
Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical Center Alkmaar, 2014* 48
Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Spanish National Health System, 2014* 49
Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Carlos III Health Institute, 2014* 50
Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Nagasaki Evaluation Organization for Clinical Interventions, 2014* 51
Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Ono Municipal Hospital, 2014* 52
Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Roma La Sapienza, 2014* 53

List of Figures

Community Acquired Pneumonia Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Community Acquired Pneumonia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Community Acquired Pneumonia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Community Acquired Pneumonia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Community Acquired Pneumonia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Community Acquired Pneumonia Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Community Acquired Pneumonia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Community Acquired Pneumonia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Community Acquired Pneumonia to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
Community Acquired Pneumonia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Community Acquired Pneumonia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Community Acquired Pneumonia to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
Community Acquired Pneumonia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Community Acquired Pneumonia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Community Acquired Pneumonia Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Community Acquired Pneumonia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Community Acquired Pneumonia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Community Acquired Pneumonia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Community Acquired Pneumonia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Community Acquired Pneumonia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Community Acquired Pneumonia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Community Acquired Pneumonia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Community Acquired Pneumonia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
GlobalData Methodology 102

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.